ATORVALIQ FDA approval date
The FDA approved ATORVALIQ on 1 Feb 2023.
- FDA approval date
- 1 Feb 2023
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as ATORVASTATIN CALCIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2023-02-01Day | ATORVALIQ | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213260", "applicant_as_listed_by_fda": "CMP DEV LLC", "brand_names": ["ATORVALIQ"], "active_ingredients": ["ATORVASTATIN CALCIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230201", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |